MAG-DHA: Clinical Trials

2 trials of MAG-DHA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 21Terminated 1

Follow MAG-DHA: new trials by email Literature Review of MAG-DHA trials Research Report on MAG-DHA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity
MAG-DHA, Oleic acid - PPROM
Not applicableUnknownUniversité de Sherbrooke702018-12-032018-11-20
Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)
MAG-DHA, Placebo - Cystic Fibrosis
Phase 2TerminatedSCF Pharma112015-10-012017-10-04

Conditions studied

Cystic Fibrosis (1)  ·  Inflammation (1)  ·  Premature Birth (1)  ·  Preterm Premature Rupture of the Membranes (1)

Sponsors

SCF Pharma (1)  ·  Université de Sherbrooke (1)

Countries

Canada (1)

Results publications

PMID 22863555, PMID 25781052, PMID 29861448